Bio Blast Pharma Company Profile (NASDAQ:ORPN)

About Bio Blast Pharma

Bio Blast Pharma Ltd. (BioBlast) is a development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations. The Company has several drug candidates in clinical or preclinical development targeting neuromuscular/central nervous system (CNS) and mitochondrial diseases. Its drug candidates include Trehalose IV Solution, BB-FA (Bioblast-Friedreich's ataxia) and BBrm-02. The Company's product candidate platforms include Protein Stabilizing Platform, Read-through Platform and Mitochondrial Protein Replacement Platform.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: ORPN
CUSIP:

Key Metrics:

Previous Close: $1.77
50 Day Moving Average: $1.72
200 Day Moving Average: $1.99
52-Week Range: $16,391,000.00 - $1.50
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -2.04
P/E Growth: 0.00
Market Cap: $29.67M
Outstanding Shares: 16,391,000
Beta: 0.09

Profitability:

Return on Equity: -39.49%
Return on Assets: -35.64%

Debt:

Current Ratio: 11.51%
Quick Ratio: 11.51%

Additional Links:

Companies Related to Bio Blast Pharma:

Consensus Ratings for Bio Blast Pharma (NASDAQ:ORPN) (?)

Ratings Breakdown:	4 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$23.75 (1,204.95% upside)

Analysts' Ratings History for Bio Blast Pharma (NASDAQ:ORPN)

Show:

Date	Firm	Action	Rating	Price Target
9/13/2016	Roth Capital	Reiterated Rating	Buy	$15.00
7/11/2016	Rodman & Renshaw	Reiterated Rating	Buy
1/28/2016	HC Wainwright	Initiated Coverage	Buy	$25.00
11/27/2015	Oppenheimer Holdings Inc.	Reiterated Rating	Outperform	$32.00

(Data available from 9/26/2014 forward)

Earnings History for Bio Blast Pharma (NASDAQ:ORPN)

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
11/15/2016
8/25/2016	Q2	($0.27)	($0.22)	View	N/A
5/25/2016	Q1	($0.29)	($0.32)	View	N/A
2/23/2016	Q4	($0.25)	($0.34)	View	N/A
11/17/2015	Q3	($0.29)	($0.25)	View	N/A
8/21/2015	Q2	($0.28)	($0.26)	View	N/A
5/19/2015	Q115	($0.25)	($0.23)	View	N/A
2/17/2015	Q414	($0.16)	($0.22)	View	N/A
11/21/2014		($0.09)	($0.16)	View	N/A
8/29/2014	Q214	($0.09)	($0.10)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Bio Blast Pharma (NASDAQ:ORPN)

Current Year EPS Consensus Estimate: $-1.03 EPS
Next Year EPS Consensus Estimate: $-0.89 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.33)	($0.26)	($0.30)
Q2 2016	1	($0.33)	($0.33)	($0.33)
Q3 2016	1	($0.22)	($0.22)	($0.22)
Q4 2016	1	($0.23)	($0.23)	($0.23)

(Data provided by Zacks Investment Research)

Dividend History for Bio Blast Pharma (NASDAQ:ORPN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Bio Blast Pharma (NASDAQ:ORPN)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Bio Blast Pharma (NASDAQ:ORPN)

Date	Headline
	Bioblast’s Special Medical Advisor to Make a Presentation Today On Trehalose as a Potential Therapeutic Agent for OPMD (NASDAQ:ORPN) finance.yahoo.com - September 26 at 11:24 AM
	How Analysts Rated Bio Blast Pharma Ltd (NASDAQ:ORPN) Last Week? - Post News (NASDAQ:ORPN) www.kentuckypostnews.com - September 24 at 6:00 PM
	Under the Microscope, Zeroing in at Bio Blast Pharma Ltd. (NASDAQ:ORPN) - Duncan Research (NASDAQ:ORPN) www.duncanindependent.com - September 22 at 11:26 AM
	Bio Blast Pharma Ltd. (NASDAQ: ORPN) Buy Rating Reiterated at Roth Capital - BNB Daily (blog) (NASDAQ:ORPN) www.baseball-news-blog.com - September 14 at 10:55 AM
	BioBlast Pharma (ORPN) Announces Strong Results from HOPEMD Extension Study - StreetInsider.com (NASDAQ:ORPN) www.streetinsider.com - September 12 at 11:13 AM
	Bioblast Pharma Reports Results of a Clinical Trial of Trehalose in Oculopharyngeal Muscular Dystrophy (OPMD) Patients (NASDAQ:ORPN) finance.yahoo.com - September 12 at 11:13 AM
	Bioblast Pharma Announces Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference on ... - EIN News (press release) (NASDAQ:ORPN) www.einnews.com - September 8 at 10:29 AM
	Bioblast Pharma Announces Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference on September 12, 2016 (NASDAQ:ORPN) finance.yahoo.com - September 7 at 10:09 AM
	Can Shares Of Bio Blast Pharma Ltd. (NASDAQ:ORPN) Get To $19? - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - August 29 at 6:27 PM
	Bioblast Pharma Reports Second Quarter 2016 Financial Results - Yahoo Finance (NASDAQ:ORPN) finance.yahoo.com - August 26 at 9:41 AM
	Bio Blast Pharma reports Q2 results (NASDAQ:ORPN) seekingalpha.com - August 25 at 11:48 AM
	Bio Blast reports 2Q loss (NASDAQ:ORPN) sg.finance.yahoo.com - August 25 at 11:48 AM
	Bio Blast Pharma Ltd. (NASDAQ:ORPN) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - August 22 at 6:39 PM
	Will Bio Blast Pharma Ltd. (NASDAQ:ORPN) Hit $19 Price Target? - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - August 16 at 6:49 PM
	Bio Blast Pharma Ltd. (ORPN) Updated Price Targets - FTSE News ... - FTSE News (NASDAQ:ORPN) www.ftsenews.co.uk - August 2 at 6:59 PM
	Trending Stock Analysis: Bio Blast Pharma Ltd. (NASDAQ:ORPN) - News Oracle (NASDAQ:ORPN) www.newsoracle.com - July 26 at 9:56 AM
	Can Shares Of Bio Blast Pharma Ltd. (NASDAQ:ORPN) Hit $19? - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - July 25 at 6:51 PM
	Checking in on Stock Volatility for: Bio Blast Pharma Ltd. (NASDAQ:ORPN) - Engelwood Daily (NASDAQ:ORPN) www.engelwooddaily.com - July 21 at 7:00 PM
	Broker Outlook For Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN) www.fiscalstandard.com - July 21 at 7:00 PM
	Top Stories: Bio Blast Pharma (NASDAQ:ORPN), Neptune Technologies & Bioressources (NASDAQ:NEPT), Ellington ... - KC Register (NASDAQ:ORPN) www.kcregister.com - July 19 at 7:36 AM
	Next Weeks Broker Price Targets For Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN) www.fiscalstandard.com - July 19 at 7:36 AM
	Is $19 Price Target Attainable For Bio Blast Pharma Ltd. (NASDAQ:ORPN)? - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - July 19 at 7:36 AM
	Were Analysts Bearish Bio Blast Pharma Ltd (NASDAQ:ORPN) This Week? - Press Telegraph (NASDAQ:ORPN) presstelegraph.com - July 19 at 7:36 AM
	Shares Moving Down on the Week: Bio Blast Pharma Ltd. (NASDAQ:ORPN) - Engelwood Daily (NASDAQ:ORPN) www.engelwooddaily.com - July 16 at 6:12 PM
	Strong Sell Calls For Bio Blast Pharma Ltd. (NASDAQ:ORPN) At 0 - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - July 12 at 6:57 PM
	Bio Blast Pharma Ltd. Stock Momentum Hits Extreme Weakness - CML News (NASDAQ:ORPN) news.cmlviz.com - July 11 at 6:41 PM
	How Many Bio Blast Pharma Ltd (NASDAQ:ORPN)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:ORPN) www.consumereagle.com - July 11 at 6:41 PM
	Broker Outlook For The Week Ahead Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN) www.fiscalstandard.com - July 5 at 11:10 AM
	Tesaro (TSRO) in Focus: Stock Adds 8.6% in Session (NASDAQ:ORPN) finance.yahoo.com - July 1 at 8:29 AM
	Bio Blast Pharma Ltd. (ORPN) Updated Price Targets - FTSE News (NASDAQ:ORPN) www.ftsenews.co.uk - June 30 at 6:58 PM
	Calithera Biosciences (CALA) Jumps: Stock Rises 7.6% (NASDAQ:ORPN) finance.yahoo.com - June 29 at 8:30 AM
	Strong Sell Calls Recommendations For Bio Blast Pharma Ltd. (NASDAQ:ORPN) At 0 - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - June 27 at 6:39 PM
	Are Analysts Bearish Bio Blast Pharma Ltd (NASDAQ:ORPN) After Last Week? - Engelwood Daily (NASDAQ:ORPN) www.engelwooddaily.com - June 27 at 10:50 AM
	Retrophin (RTRX) RE-024 Positive in Physician-Initiated Study (NASDAQ:ORPN) finance.yahoo.com - June 24 at 9:15 AM
	ArQule (ARQL) Shows Strength: Stock Adds 8% in Session (NASDAQ:ORPN) finance.yahoo.com - June 23 at 8:25 AM
	Strong Buy Calls Count For Bio Blast Pharma Ltd. (NASDAQ:ORPN) At 2 - Investor Newswire (NASDAQ:ORPN) www.investornewswire.com - June 20 at 6:30 PM
	This Weeks Broker Views For Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN) www.fiscalstandard.com - June 20 at 8:17 AM
	Bio Blast Pharma Ltd. (ORPN) Current Analyst Ratings - Fiscal Standard (NASDAQ:ORPN) www.fiscalstandard.com - June 16 at 10:52 AM
	Should You Get Rid of Valeant Pharmaceuticals (VRX) Now? (NASDAQ:ORPN) finance.yahoo.com - June 16 at 8:31 AM
	Resolute Forest Products Inc. (NYSE:RFP) plummeted -6.48%: Bio Blast Pharma Ltd. (NASDAQ:ORPN), Avnet, Inc ... - KC Register (NASDAQ:ORPN) www.kcregister.com - June 14 at 6:24 PM
	Zafgen (ZFGN) Presents Favorable New Data on Beloranib (NASDAQ:ORPN) www.zacks.com - June 13 at 6:15 PM
	New Strong Buy Stocks for June 13th (NASDAQ:ORPN) www.zacks.com - June 13 at 9:38 AM
	BioBlast Pharma (ORPN) Plans Trehalose IV Phase 2b in OPMD; Will Evaluate in Other Orphan Diseases - StreetInsider.com (NASDAQ:ORPN) www.streetinsider.com - June 9 at 9:39 AM
	6:02 am Bio Blast Pharma announces plans to initiate a Phase 2b trial with trehalose IV solution in OPMD during the second half of 2016, CFO to leave the co, CEO Colin Foster leaves position but remains on the Board, Executive Chairman Fred (NASDAQ:ORPN) finance.yahoo.com - June 9 at 6:02 AM
	Bioblast Pharma Updates Corporate Plans (NASDAQ:ORPN) finance.yahoo.com - June 9 at 6:00 AM
	Nokia Corporation (ADR) (NYSE:NOK) increased 0.53%: Bio Blast Pharma Ltd. (NASDAQ:ORPN), IdaCorp, Inc. (NYSE ... - KC Register (NASDAQ:ORPN) www.kcregister.com - June 6 at 10:22 AM
	MakeMyTrip Limited (NASDAQ:MMYT) decreased -2.35%: Bio Blast Pharma Ltd. (NASDAQ:ORPN), Pacira ... - KC Register (NASDAQ:ORPN) www.kcregister.com - June 6 at 10:22 AM
	5 Stocks Under $5 With Potential (SIRI,GRPN,KTOS) (NASDAQ:ORPN) www.investopedia.com - June 2 at 11:18 AM
	Analysts Expect Bio Blast Pharma Ltd (NASDAQ:ORPN) to Post ($0.29) EPS - Let Me Know About This (NASDAQ:ORPN) www.lmkat.com - May 31 at 1:17 AM
	Next Weeks Broker Price Targets For Bio Blast Pharma Ltd. (ORPN) - Share Trading News (NASDAQ:ORPN) www.sharetrading.news - May 30 at 6:46 PM